MAYINGLONG HEMORRHOIDS- zinc oxide, petrolatum, lanolin ointment 
Mayinglong Pharmaceutical Group Co Ltd

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

MAYINGLONG HEMORRHOIDS OINTMENT

Active Ingredients

Zinc Oxide 0.8g Astrigent

Petrolatum 7.85g Protectant

Purpose

Astrigent

Protectant

Protectant

Uses

helps relieve the local itching and discomfort associated with hemorrhoids

temporarily shrinks hemorrhoidal tissue and relieves burning

temporarily provides a coating for relief of anorectal discomforts

temporarily protects the inflamed, irritated anorectal surface to help make bowel movements less painful

Warning

For external and /or intrarectal use only. Not for oral use.

Stop use

bleeding occurs

condition worses or does not improve within 7 days

introduction of applicator into the rectum causes additional pain

Warning

Apply it carfully during pregnancy.

Warning

Keep this and all drugs out of reach of children.

Direction

Apply properly onto anus or apply on affected areas twice a day.

Other information

Store at 20-25 degree Centigrade (68-77 degree Fahrenheit)

Inactive ingredients

Musk Ketone

Pearl (Hyriopsis Cumming II)

Borneol

Sodium Borate

Drug Facts

mayinglong box18

MAYINGLONG HEMORRHOIDS 
zinc oxide, petrolatum, lanolin ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:68511-993
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
ZINC OXIDE (UNII: SOI2LOH54Z) (ZINC OXIDE - UNII:SOI2LOH54Z) ZINC OXIDE800 mg  in 10000 mg
PETROLATUM (UNII: 4T6H12BN9U) (PETROLATUM - UNII:4T6H12BN9U) PETROLATUM7850 mg  in 10000 mg
Inactive Ingredients
Ingredient NameStrength
MUSK KETONE (UNII: 483V3E1L6J)  
PEARL (HYRIOPSIS CUMINGII) (UNII: A75L5FZ40U)  
BORNEOL (UNII: M89NIB437X)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
LANOLIN (UNII: 7EV65EAW6H)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:68511-993-0210000 mg in 1 CARTON; Type 0: Not a Combination Product10/25/2017
2NDC:68511-993-034000 mg in 1 CARTON; Type 0: Not a Combination Product08/19/2019
3NDC:68511-993-0420000 mg in 1 CARTON; Type 0: Not a Combination Product08/19/2019
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart34612/15/2003
Labeler - Mayinglong Pharmaceutical Group Co Ltd (526823828)
Registrant - Mayinglong Pharmaceutical Group Co Ltd (526823828)
Establishment
NameAddressID/FEIBusiness Operations
Mayinglong Pharmaceutical Group Co Ltd526823828manufacture(68511-993)

Revised: 8/2019
Document Id: 907e01f8-0307-5d46-e053-2a95a90adcb8
Set id: 83f95bd2-f297-37c9-e053-2a91aa0a96ea
Version: 2
Effective Time: 20190819
 
Mayinglong Pharmaceutical Group Co Ltd